Cargando…
Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer
The molecular underpinnings of acquired resistance to carboplatin are poorly understood and often inconsistent between in vitro modeling studies. After sequential treatment cycles, multiple isogenic clones reached similar levels of resistance, but significant transcriptional heterogeneity. Gene-expr...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206019/ https://www.ncbi.nlm.nih.gov/pubmed/35715421 http://dx.doi.org/10.1038/s41540-022-00230-z |
_version_ | 1784729253267374080 |
---|---|
author | Wenzel, Alexander T. Champa, Devora Venkatesh, Hrishi Sun, Si Tsai, Cheng-Yu Mesirov, Jill P. Bui, Jack D. Howell, Stephen B. Harismendy, Olivier |
author_facet | Wenzel, Alexander T. Champa, Devora Venkatesh, Hrishi Sun, Si Tsai, Cheng-Yu Mesirov, Jill P. Bui, Jack D. Howell, Stephen B. Harismendy, Olivier |
author_sort | Wenzel, Alexander T. |
collection | PubMed |
description | The molecular underpinnings of acquired resistance to carboplatin are poorly understood and often inconsistent between in vitro modeling studies. After sequential treatment cycles, multiple isogenic clones reached similar levels of resistance, but significant transcriptional heterogeneity. Gene-expression based virtual synchronization of 26,772 single cells from 2 treatment steps and 4 resistant clones was used to evaluate the activity of Hallmark gene sets in proliferative (P) and quiescent (Q) phases. Two behaviors were associated with resistance: (1) broad repression in the P phase observed in all clones in early resistant steps and (2) prevalent induction in Q phase observed in the late treatment step of one clone. Furthermore, the induction of IFNα response in P phase or Wnt-signaling in Q phase were observed in distinct resistant clones. These observations suggest a model of resistance hysteresis, where functional alterations of the P and Q phase states affect the dynamics of the successive transitions between drug exposure and recovery, and prompts for a precise monitoring of single-cell states to develop more effective schedules for, or combination of, chemotherapy treatments. |
format | Online Article Text |
id | pubmed-9206019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-92060192022-06-19 Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer Wenzel, Alexander T. Champa, Devora Venkatesh, Hrishi Sun, Si Tsai, Cheng-Yu Mesirov, Jill P. Bui, Jack D. Howell, Stephen B. Harismendy, Olivier NPJ Syst Biol Appl Article The molecular underpinnings of acquired resistance to carboplatin are poorly understood and often inconsistent between in vitro modeling studies. After sequential treatment cycles, multiple isogenic clones reached similar levels of resistance, but significant transcriptional heterogeneity. Gene-expression based virtual synchronization of 26,772 single cells from 2 treatment steps and 4 resistant clones was used to evaluate the activity of Hallmark gene sets in proliferative (P) and quiescent (Q) phases. Two behaviors were associated with resistance: (1) broad repression in the P phase observed in all clones in early resistant steps and (2) prevalent induction in Q phase observed in the late treatment step of one clone. Furthermore, the induction of IFNα response in P phase or Wnt-signaling in Q phase were observed in distinct resistant clones. These observations suggest a model of resistance hysteresis, where functional alterations of the P and Q phase states affect the dynamics of the successive transitions between drug exposure and recovery, and prompts for a precise monitoring of single-cell states to develop more effective schedules for, or combination of, chemotherapy treatments. Nature Publishing Group UK 2022-06-17 /pmc/articles/PMC9206019/ /pubmed/35715421 http://dx.doi.org/10.1038/s41540-022-00230-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wenzel, Alexander T. Champa, Devora Venkatesh, Hrishi Sun, Si Tsai, Cheng-Yu Mesirov, Jill P. Bui, Jack D. Howell, Stephen B. Harismendy, Olivier Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer |
title | Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer |
title_full | Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer |
title_fullStr | Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer |
title_full_unstemmed | Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer |
title_short | Single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer |
title_sort | single-cell characterization of step-wise acquisition of carboplatin resistance in ovarian cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206019/ https://www.ncbi.nlm.nih.gov/pubmed/35715421 http://dx.doi.org/10.1038/s41540-022-00230-z |
work_keys_str_mv | AT wenzelalexandert singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer AT champadevora singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer AT venkateshhrishi singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer AT sunsi singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer AT tsaichengyu singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer AT mesirovjillp singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer AT buijackd singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer AT howellstephenb singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer AT harismendyolivier singlecellcharacterizationofstepwiseacquisitionofcarboplatinresistanceinovariancancer |